Poorer survival of nulliparous women with endometrial carcinoma

Cancer

Volumn 82, Issue 7, 1998, Pages 1328-1333

  Salvesen, Helga B ^a,b   Akslen, Lars A ^b   Albrektsen, Grethe ^a   Iversen, Ole E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endometrial carcinoma; Parity; Prognosis; Survival

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CELL DIFFERENTIATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NULLIPARA; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0032055150     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980401)82:7<1328::AID-CNCR16>3.0.CO;2-8     Document Type: Article

References (37)

1. The Cancer Registry of Norway. Cancer in Norway, 1992. Oslo: Institute for Epidemiological Cancer Research, 1995:60-1.
2. Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer, 1988. Cancer 1993;71:1460-3.
3. Rose PG. Endometrial carcinoma. N Engl J Med 1996; 335:640-9.
4. Salvesen HB, Akslen LA, Iversen T, Iversen OE. Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol. 1997;104:1302-7.
5. Iversen OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986;155:770-6.
6. Pisani AL, Barbuto DA, Chen D, Ramos L, Lagasse LD, Karlan BY. HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma. Obstet Gynecol 1995;85:729-34.
7. Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ, Iacopetta BJ. Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 1996;74:562-7.
8. Abeler VM, Kjørstad KE. Endometrial adenocarcinoma in Norway: a study of a total population. Cancer 1991;67:3093-103.
9. Salvesen HB, Iversen OE, Akslen LA. Independent prognostic importance of microvessel density in endometrial carcinoma. Br J Cancer. 1998;77(7).
10. Kvåle G, Heuch I, Ursin G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res 1988;48:6217-21.
11. Albrektsen G, Heuch I, Tretli S, Kvåle G. Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 Norwegian women. Int J Cancer 1995;61:485-90.
12. De Ward F, De Ridder CM, Baanders-van Halewyn EA, Slotboom BJ. Endometrial cancer in a cohort screened for breast cancer. Eur J Cancer Prev 1996;6:99-104.
13. Franceschi S. Reproductive factors and cancer of the breast, ovary and endometrium. Eur J Cancer Clin Oncol 1989; 25:1933-43.
14. Parazzini F, La Vecchia C, Negri E, Fedele L, Balotta F. Reproductive factors and risk of endometrial cancer. Am J Obstet Gynecol 1991;164:522-7.
15. Korzeniowski S, Dyba T. Reproductive history and prognosis in patients with operable breast cancer. Cancer 1994; 74:1591-4.
16. Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991;49:526-30.
17. Bjørge T, Kravdal Ø. Reproductive factors and prognosis of uterine cervical cancer in Norway. Br J Cancer 1996;74:1843-6.
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
19. Cox DR. Regression models and life-tables. J Roy Stat Soc 1972;34:187-220.
20. Dixon WJ. BMDP statistical software manual. Berkeley: University of California Press, 1992.
21. Tretli S, Magnus K. Height and weight in relation to uterine corpus cancer morbidity and mortality: a follow up study of 570,000 women in Norway. Int J Cancer 1990;46:165-72.
22. Marth C, Koza A, Müller-Holzner E, Hetzel H, Fuith LC, Dapunt O. Prognostically relevant factors in the malignant mixed müllerian tumour. Geburtsh u Frauenheilk 1990; 50:605-9.
23. Wagenius G, Bergström R, Strang P, Gerdes U, Rogo K, Tribukait B, et al. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res 1992;12:725-32.
24. Key TJA, Pike MC. The dose-effect relationship between unopposed oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-12.
25. Beresford SAA, Weiss NS, Voigt LF, McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 1997;349:458-61.
26. Hulka BS, Kaukman DG, Fowler WC, Grimson RC, Greenberg GB. Predominance of early endometrial cancer after long-term estrogen use. JAMA 1980;244:2419-22.
27. Mc Donald TW, Malkasian GD, Gaffey TA. Endometrial cancer associated with feminizing ovarian tumor and polycystic ovarian disease. Obstet Gynecol 1976;49:654-8.
28. Anderson B, Connor JP, Andrews JI, Davis CS, Buller RE, Sorosky JI, et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol 1996;174:1171-9.
29. Menczer J, Krissi H, Chetrit A, Gaylor J, Lerner L, Ben-Baruch G, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol 1995;173:774-8.
30. Obermair A, Hanzal E, Schreiner-Frech I, Buxbaum P, Bancher-Todesca D, Thoma M, et al. Influence of delay on established prognostic factors in endometrial cancer. Anticancer Res 1996;16:947-50.
31. Forsmo S, Buhaug H, Stalsberg H. Use of pap-smears in a population without a mass screening program. Acta Obstet Gynecol Scand 1994;73:824-8.
32. Koopmanschap MA, van Oortmarssen GJ, Van Agt HMA, van Ballegooijen M, Habbema JDF, Lubbe KTN. Cervical-cancer screening: attendance and cost-effectiveness. Int J Cancer 1990;45:410-5.
33. Samet JM, Hunt WC, Lerchen ML, Goodwin JS. Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. J Natl Cancer Inst 1988;80:432-8.
34. Black MM, Hankey BF, Barclay THC. Parity as a prognostic factor in young breast cancer patients. J Natl Cancer Inst 1983;70:27-30.
35. Jacobsen BK, Vollset SE, Kvåle G. Do reproductive factors influence colorectal cancer survival? J Clin Epidemiol 1995;48:1119-22.
36. Jacobsen BK, Vollset SE, Kvåle G. Reproductive factors and survival from ovarian cancer. Int J Cancer 1993;54:904-6.
37. Kravdal Ø, Hansen S. The importance of childbearing for Hodgkin's disease: new evidence from incidence and mortality models. Int J Epidemiol 1996;25:737-43.